DATATRAK International, Inc. Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2019
May 06, 2019 at 04:23 pm EDT
Share
DATATRAK International, Inc. announced unaudited consolidated financial results for the first quarter ended March 31, 2019. Revenue for the first quarter of 2019 was $1,922,108 compared to $1,754,313 for the first quarter of 2018. The company had income from operations for the three months ended March 31, 2019 of $164,673 compared to an operating loss of $111,826 for the three months ended March 31, 2018. The company's net income for the three months ended March 31, 2019 was $166,401 compared to a net loss of $109,725 for the three months ended March 31, 2018. Net income per basic and diluted share was $0.07 against $0.05 for the three months ended March 31, 2018.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
